Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Wilk

Showing results (11-20 of 247) with videos related to

Pageof 25
Sort By:
Biochemical and Biophysical Research Communications|August 14, 1981
A multicatalytic protease complex from pituitary that forms enkephalin and enkephalin containing peptidesM Orlowski, S Wilk
Biochemical Pharmacology|March 1, 1973
Absence of 3-methoxy-4-hydroxyphenylethanol in brainS Wilk, B Zimmerberg
European Journal of Biochemistry|December 11, 1976
Metabolism of gamma-glutamyl amino acids and peptides in mouse liver and kidney in vivoM Orlowski, S Wilk
European Journal of Pharmacology|September 15, 1978
Clozapine concentrations in brain regions: relationship to dopamine metabolite increaseS Wilk, M Stanley
Journal of Neurochemistry|July 1, 1983
Inhibition of rabbit brain prolyl endopeptidase by n-benzyloxycarbonyl-prolyl-prolinal, a transition state aldehyde inhibitorS Wilk, M Orlowski
The Journal of Pharmacy and Pharmacology|August 1, 1980
The differential effects of morphine, oxotremorine and antipsychotic drugs on DOPAC concentrations in rat brainM Stanley, S Wilk
Current Problems in Clinical Biochemistry|October 23, 1977
Kidney as a site of uptake and metabolism of gamma-glutamyl compoundsM Orlowski, S Wilk
European Journal of Biochemistry|May 6, 1975
Intermediates of the gamma-glutamyl cycle in mouse tissues. Influence of administration of amino acids on pyrrolidone carboxylate and gamma-glutamyl amino acidsM Orlowski, S Wilk
Life Sciences|May 14, 1979
Striatal DOPAC elevation predicts antipsychotic efficacy of metoclopramideM Stanley, S Wilk
European Journal of Pharmacology|January 7, 1977
Perlapine and dopamine metabolism: prediction of antipsychotic efficacyS Wilk, M Stanley
Pageof 25

Showing results (11-20 of 247) with videos related to

Sort By:
Pageof 25
Biochemical and Biophysical Research Communications|August 14, 1981
A multicatalytic protease complex from pituitary that forms enkephalin and enkephalin containing peptidesM Orlowski, S Wilk
Biochemical Pharmacology|March 1, 1973
Absence of 3-methoxy-4-hydroxyphenylethanol in brainS Wilk, B Zimmerberg
European Journal of Biochemistry|December 11, 1976
Metabolism of gamma-glutamyl amino acids and peptides in mouse liver and kidney in vivoM Orlowski, S Wilk
European Journal of Pharmacology|September 15, 1978
Clozapine concentrations in brain regions: relationship to dopamine metabolite increaseS Wilk, M Stanley
Journal of Neurochemistry|July 1, 1983
Inhibition of rabbit brain prolyl endopeptidase by n-benzyloxycarbonyl-prolyl-prolinal, a transition state aldehyde inhibitorS Wilk, M Orlowski
The Journal of Pharmacy and Pharmacology|August 1, 1980
The differential effects of morphine, oxotremorine and antipsychotic drugs on DOPAC concentrations in rat brainM Stanley, S Wilk
Current Problems in Clinical Biochemistry|October 23, 1977
Kidney as a site of uptake and metabolism of gamma-glutamyl compoundsM Orlowski, S Wilk
European Journal of Biochemistry|May 6, 1975
Intermediates of the gamma-glutamyl cycle in mouse tissues. Influence of administration of amino acids on pyrrolidone carboxylate and gamma-glutamyl amino acidsM Orlowski, S Wilk
Life Sciences|May 14, 1979
Striatal DOPAC elevation predicts antipsychotic efficacy of metoclopramideM Stanley, S Wilk
European Journal of Pharmacology|January 7, 1977
Perlapine and dopamine metabolism: prediction of antipsychotic efficacyS Wilk, M Stanley
Pageof 25